Industry reports
Editor highlights

Gastric Cancer Research Reports, April 2014

You might be interested in: microbiology, disease testing, cancer, more »


 

1-10 of 23 reports for Gastric Cancer
Gastric Cancer Partnering 2009-2014

Gastric Cancer Partnering 2009-2014

  • $ 995
  • Industry report
  • March 2014
  • by Currentpartnering

... Report contains over 35 links to online copies of actual gastric cancer deals and contract documents as submitted to the securities exchange commission by companies and their partners, where available ...

immatics biotechnologies GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

immatics biotechnologies GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... Earlier programs in several other tumor types including gastric cancer, non-small-cell lung cancer and prostate cancer which are being developed in collaboration with roche. Immatics is headquartered ...

Patrys Limited (PAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Patrys Limited (PAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... Technologies to develop natural human antibody-based therapeutic products for the treatment of cancer and many other diseases. Its product pipeline includes pat-sc1 used for the treatment of gastric cancer; pat ...

Viralytics Ltd. (VLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Viralytics Ltd. (VLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... On gastric cancer with evatak, ovarian cancer with evatak, and melanoma studies with cva13, cva15, cva18, and cva21 dafv. It has its presence in queensland, australia. Viralytics is headquartered in sydney ...

Kinex Pharmaceuticals, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kinex Pharmaceuticals, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... Cancer, acute myeloid leukemia, chronic myelogenous leukemia, psoriasis, brain cancer, gastric cancer, solid tumors and immunomodulation. The company has licensing agreement with zenith technology ...

Fresenius Biotech GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Fresenius Biotech GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... And distributes biopharmaceuticals in the areas of immunology, oncology and transplantation medicine. The company manufactures therapeutics and antibodies targeting therapeutic conditions such as gastric cancer ...

Pathology: Miraculins Inc. (MOM)

Pathology: Miraculins Inc. (MOM)

  • $ 750
  • Company report
  • January 2014
  • by Global Data

... Pancreatic cancer, and gastric cancer programs. The company utilizes the b.E.S.T platform technology for screening and identification of target proteins and peptides related to diseases. Miraculins ...

Pacific Edge Limited (PEB) - Product Pipeline Analysis, 2013 Update

Pacific Edge Limited (PEB) - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • December 2013
  • by Global Data

... Endometrial cancer detection assay - product description 15gastric cancer triage immunoassay - product status 16gastric cancer triage immunoassay - product description 16prognostic assay - melanoma ...

Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth

Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth

  • $ 3 500
  • Industry report
  • December 2013
  • by GBI Research

... Antibodies market in gastric and esophageal cancers to 2019- developmental pipeline 224.1 gastric cancer 224.1.1 Overall pipeline 224.1.2 Molecular targets 244.1.3 Clinical trials 264 ...

Gastric Cancer Global Clinical Trials Review, H2, 2013

Gastric Cancer Global Clinical Trials Review, H2, 2013

  • $ 2 500
  • Industry report
  • November 2013
  • by Global Data

... Clinical trials review, h2, 2013" provides data on the gastric cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on gastric cancer ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.